Payment overview · 2025
General Payments
184 reported records · 19 companies
Healthcare provider profile · identity verified
Allopathic & Osteopathic Physicians|Surgery|Vascular Surgery · ASTORIA, NY · NPI 1336364991
Verified facts
CMS Open Payments records show Christopher John Smolock, M.D. received $25,201.11 in general payments during 2025 across 184 reported records.
Cook Incorporated accounted for 22.6% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 39 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
184 reported records · 19 companies
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Cook Incorporated | Unresolved — no canonical attribution shown | $5,700.37 | 22.6% | 3 | 2025 |
| Penumbra, Inc. | Unresolved — no canonical attribution shown | $5,288.64 | 21.0% | 13 | 2025 |
| Medtronic, Inc. |
Medtronic, Inc. exact · evidence 2025-07-22 |
$4,486.37 | 17.8% | 55 | 2025 |
| Bard Peripheral Vascular, Inc. | Unresolved — no canonical attribution shown | $2,268.52 | 9.0% | 18 | 2025 |
| Wilson Cook Medical Incorporated | Unresolved — no canonical attribution shown | $1,240.00 | 4.9% | 1 | 2025 |
| Cook Medical LLC | Unresolved — no canonical attribution shown | $1,231.31 | 4.9% | 26 | 2025 |
| Tactile Systems Technology Inc | Unresolved — no canonical attribution shown | $1,014.81 | 4.0% | 25 | 2025 |
| Bolton Medical Inc | Unresolved — no canonical attribution shown | $820.14 | 3.2% | 10 | 2025 |
| Shockwave Medical, Inc | Unresolved — no canonical attribution shown | $772.66 | 3.1% | 7 | 2025 |
| InspireMD Ltd | Unresolved — no canonical attribution shown | $526.70 | 2.1% | 6 | 2025 |
| Becton, Dickinson and Company | Unresolved — no canonical attribution shown | $468.73 | 1.9% | 1 | 2025 |
| W. L. Gore & Associates, Inc. | Unresolved — no canonical attribution shown | $442.69 | 1.8% | 4 | 2025 |
| Stryker Corporation | Unresolved — no canonical attribution shown | $321.03 | 1.3% | 3 | 2025 |
| Philips North America LLC | Unresolved — no canonical attribution shown | $216.00 | 0.9% | 2 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $215.61 | 0.9% | 3 | 2025 |
| Smith+Nephew, Inc. | Unresolved — no canonical attribution shown | $114.65 | 0.5% | 4 | 2025 |
| Endologix LLC | Unresolved — no canonical attribution shown | $27.99 | 0.1% | 1 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $25.38 | 0.1% | 1 | 2025 |
| Artivion, Inc. | Unresolved — no canonical attribution shown | $19.51 | 0.1% | 1 | 2025 |
What were the payments for?
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $13,300.67 | 177 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,220.00 | 4 |
| Travel and Lodging | $2,680.44 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Indigo System Normalized: indigo system |
Device | Penumbra, Inc. | $4,995.43 | 9 | 2025 |
Source payment records
|
|||||
| ZENITH ALPHA Normalized: zenith alpha |
Device | Cook Incorporated, Cook Medical LLC | $2,774.63 | 6 | 2025 |
Source payment records
|
|||||
| ENDURANT IIS Normalized: endurant iis |
Device | Medtronic, Inc. | $2,354.20 | 32 | 2025 |
Source payment records
|
|||||
| RotarexS 6 F x 135 cm Normalized: rotarexs 6 f x 135 cm |
Device | Bard Peripheral Vascular, Inc., Becton, Dickinson and Company | $1,171.33 | 7 | 2025 |
Source payment records
|
|||||
| Flexitouch Plus Normalized: flexitouch plus |
Device | Tactile Systems Technology Inc | $1,014.81 | 25 | 2025 |
Source payment records
|
|||||
| Nimbl Normalized: nimbl |
Device | Tactile Systems Technology Inc | $1,014.81 | 25 | 2025 |
Source payment records
|
|||||
| VALIANT CAPTIVIA Normalized: valiant captivia |
Device | Medtronic, Inc. | $946.32 | 11 | 2025 |
Source payment records
|
|||||
| LUTONIX Drug Coated Balloon Normalized: lutonix drug coated balloon |
Device | Bard Peripheral Vascular, Inc. | $855.20 | 6 | 2025 |
Source payment records
|
|||||
| Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter Normalized: shockwave ivl system with the shockwave c2 coronary ivl catheter |
Device | Shockwave Medical, Inc | $772.66 | 7 | 2025 |
Source payment records
|
|||||
| HAWKONE Normalized: hawkone |
Device | Medtronic, Inc. | $612.34 | 6 | 2025 |
Source payment records
|
|||||
| Crosser IQ Normalized: crosser iq |
Device | Bard Peripheral Vascular, Inc. | $610.21 | 5 | 2025 |
Source payment records
|
|||||
| RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM Normalized: relay thoracic stent graft with plus delivery system |
Device | Bolton Medical Inc | $599.47 | 7 | 2025 |
Source payment records
|
|||||
| CGuard Prime Carotid Stent System Normalized: cguard prime carotid stent system |
Device | InspireMD Ltd | $526.70 | 6 | 2025 |
Source payment records
|
|||||
| ZENITH SPIRAL-Z Normalized: zenith spiral z |
Device | Cook Medical LLC | $490.17 | 12 | 2025 |
Source payment records
|
|||||
| TREO ABDOMINAL STENT-GRAFT SYSTEM Normalized: treo abdominal stent graft system |
Device | Bolton Medical Inc | $390.96 | 6 | 2025 |
Source payment records
|
|||||
| GORE VIABAHN VBX Balloon Expandable Endo Normalized: gore viabahn vbx balloon expandable endo |
Device | W. L. Gore & Associates, Inc. | $333.72 | 3 | 2025 |
Source payment records
|
|||||
| Penumbra System Normalized: penumbra system |
Device | Penumbra, Inc. | $293.21 | 4 | 2025 |
Source payment records
|
|||||
| CT THROMBECTOMY SYSTEM KIT Normalized: ct thrombectomy system kit |
Device | Stryker Corporation | $283.16 | 2 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER CATHETER, S Normalized: flowtriever catheter s |
Device | Stryker Corporation | $283.16 | 2 | 2025 |
Source payment records
|
|||||
| ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM Normalized: icast covered stent system 6mmx22mmx120cm |
Device | Cook Medical LLC | $264.57 | 3 | 2025 |
Source payment records
|
|||||
| VISI-PRO Normalized: visi pro |
Device | Medtronic, Inc. | $215.26 | 1 | 2025 |
Source payment records
|
|||||
| HELI-FX ENDOANCHOR SYSTEM Normalized: heli fx endoanchor system |
Device | Medtronic, Inc. | $195.14 | 4 | 2025 |
Source payment records
|
|||||
| General - Vascular Intervention Normalized: general vascular intervention |
Device | Boston Scientific Corporation | $185.86 | 2 | 2025 |
Source payment records
|
|||||
| ABRE Normalized: abre |
Device | Medtronic, Inc. | $163.11 | 1 | 2025 |
Source payment records
|
|||||
| ZILVER PTX Normalized: zilver ptx |
Device | Cook Medical LLC | $133.38 | 1 | 2025 |
Source payment records
|
|||||
| FORS Components Normalized: fors components |
Device | Philips North America LLC | $126.72 | 1 | 2025 |
Source payment records
|
|||||
| COOK Normalized: cook |
Device | Cook Medical LLC | $123.71 | 4 | 2025 |
Source payment records
|
|||||
| COLLAGENASE SANTYL Normalized: collagenase santyl |
Drug | Smith+Nephew, Inc. | $114.65 | 4 | 2025 |
Source payment records
|
|||||
| GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis Normalized: gore excluder thoracoabdominal branch endoprosthesis |
Device | W. L. Gore & Associates, Inc. | $108.97 | 1 | 2025 |
Source payment records
|
|||||
| Bard InLay Optima Ureteral Stent with HydroGlide Guidewire Normalized: bard inlay optima ureteral stent with hydroglide guidewire |
Device | Bard Peripheral Vascular, Inc. | $100.51 | 1 | 2025 |
Source payment records
|
|||||
| Labosys Normalized: labosys |
Device | Philips North America LLC | $89.28 | 1 | 2025 |
Source payment records
|
|||||
| ZENITH Normalized: zenith |
Device | Cook Medical LLC | $45.22 | 2 | 2025 |
Source payment records
|
|||||
| FLOWTRIEVER Normalized: flowtriever |
Device | Stryker Corporation | $37.87 | 1 | 2025 |
Source payment records
|
|||||
| General - Balloons Normalized: general balloons |
Device | Boston Scientific Corporation | $29.75 | 1 | 2025 |
Source payment records
|
|||||
| Alto Abdominal Stent Graft System Normalized: alto abdominal stent graft system |
Device | Endologix LLC | $27.99 | 1 | 2025 |
Source payment records
|
|||||
| ESPRIT Normalized: esprit |
Device | Abbott Laboratories | $25.38 | 1 | 2025 |
Source payment records
|
|||||
| BIOGLUE SURGICAL ADHESIVE Normalized: bioglue surgical adhesive |
Device | Artivion, Inc. | $19.51 | 1 | 2025 |
Source payment records
|
|||||
| PHOTOFIX DECELLULARIZED BOVINE PERICARDIUM Normalized: photofix decellularized bovine pericardium |
Device | Artivion, Inc. | $19.51 | 1 | 2025 |
Source payment records
|
|||||
| Vascular Normalized: vascular |
Device | Artivion, Inc. | $19.51 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $25,201.11 · 184 records | Cook Incorporated | ABRE, Alto Abdominal Stent Graft System, BIOGLUE SURGICAL ADHESIVE, Bard InLay Optima Ureteral Stent with HydroGlide Guidewire, CGuard Prime Carotid Stent System, COLLAGENASE SANTYL, COOK, CT THROMBECTOMY SYSTEM KIT, Crosser IQ, ENDURANT IIS, ESPRIT, FLOWTRIEVER, FLOWTRIEVER CATHETER, S, FORS Components, Flexitouch Plus, GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis, GORE VIABAHN VBX Balloon Expandable Endo, General - Balloons, General - Vascular Intervention, HAWKONE, HELI-FX ENDOANCHOR SYSTEM, ICAST COVERED STENT SYSTEM, 6MMX22MMX120CM, Indigo System, LUTONIX Drug Coated Balloon, Labosys, Nimbl, PHOTOFIX DECELLULARIZED BOVINE PERICARDIUM, Penumbra System, RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM, RotarexS 6 F x 135 cm, Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter, TREO ABDOMINAL STENT-GRAFT SYSTEM, VALIANT CAPTIVIA, VISI-PRO, Vascular, ZENITH, ZENITH ALPHA, ZENITH SPIRAL-Z, ZILVER PTX | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error